Attached files
| file | filename |
|---|---|
| EX-10.18 - EX-10.18 - Orexigen Therapeutics, Inc. | d858230dex1018.htm |
| EX-10.17 - EX-10.17 - Orexigen Therapeutics, Inc. | d858230dex1017.htm |
| EX-10.36 - EX-10.36 - Orexigen Therapeutics, Inc. | d858230dex1036.htm |
| EX-31.4 - EX-31.4 - Orexigen Therapeutics, Inc. | d858230dex314.htm |
| 10-K/A - FORM 10-K/A - Orexigen Therapeutics, Inc. | d858230d10ka.htm |
Exhibit 31.3
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Michael A. Narachi, certify that:
1. I have reviewed this Amendment No. 1 to the annual report on Form 10-K/A of Orexigen Therapeutics, Inc.; and
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
| Date: January 26, 2015 |
| /s/ Michael A. Narachi |
| Michael A. Narachi |
| President and Chief Executive Officer |